 |
 |

Spectrum of Brain Changes in Patients With Congenital Muscular Dystrophy and FKRP Gene Mutations
Eugenio Mercuri, MD;
Haluk Topaloglu, MD;
Martin Brockington, BSc;
Angela Berardinelli, MD;
Anna Pichiecchio, MD;
Filippo Santorelli, MD;
Mary Rutherford, MD;
Beril Talim, MD;
Enzo Ricci, MD;
Thomas Voit, MD;
Francesco Muntoni, MD
Arch Neurol. 2006;63:251-257.
Objectives To report the spectrum of brain magnetic resonance imaging findings in 13 patients with congenital muscular dystrophy and FKRP gene mutations and to explore possible genotype-phenotype correlations.
Design We retrospectively reviewed brain magnetic resonance imaging in patients with congenital muscular dystrophy and FKRP gene mutations.
Patients Thirteen patients with congenital muscular dystrophy and mutations in the FKRP gene.
Results Five of the 13 patients had the typical phenotype originally described for congenital muscular dystrophy (MDC1C) with normal intelligence and normal brain magnetic resonance imaging while 3 other patients had isolated cerebellar cysts and mental retardation without any other sign of posterior fossa of supratentorial abnormalities. In the remaining 5 patients cerebellar cysts were associated with structural brain changes involving the posterior fossa and the cortex, ranging from focal unilateral periventricular nodular heterotopia to marked cerebellar dysplasia and pontine hypoplasia. In 2 of these 5 patients the severity and distribution of changes resembled muscle-eye-brain disease in 1 patient who had mild Walker-Warburg syndrome. The distribution of FKRP gene mutations identified in this group of patients did not reveal any obvious association with the severity of central nervous system involvement.
Conclusions The severity of central nervous system involvement observed in our patients in contrast broadly reflected the severity of the disruption of -dystroglycan glycosylation. In particular, dystroglycan expression was almost absent in the patients with muscle-eye-brain diseaselike phenotype and less severely reduced in the patients with congenital muscular dystrophy (MDC1C) with or without cerebellar cysts. This study further highlights the central role that dystroglycan has in neuronal migration.
Author Affiliations: Dubowitz Neuromuscular Centre, Department of Paediatrics (Drs Mercuri and Muntoni and Mr Brockington) and the Magnetic Resonance Imaging Unit (Dr Rutherford), Imperial College, Hammersmith Hospital Campus, London, United Kingdom; Institute of Neurology, Catholic University, Rome, Italy (Drs Mercuri and Ricci); Department of Child Neurology, Hacettepe Children's Hospital, Ankara, Turkey (Drs Topaloglu and Talim); Departments of Child Neurology (Dr Berardinelli) and Radiology (Dr Pichiecchio), Mondino Institute, Pavia, Italy; Molecular Medicine, Bambino Gesu, Rome (Dr Santorelli); and Department of Paediatrics and Paediatric Neurology, University Hospital of Essen, Germany (Dr Voit).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Abnormal vascular development in zebrafish models for fukutin and FKRP deficiency
Wood et al.
Hum Mol Genet 2011;20:4879-4890.
ABSTRACT
| FULL TEXT
Fukutin-Related Protein Alters the Deposition of Laminin in the Eye and Brain
Ackroyd et al.
J. Neurosci. 2011;31:12927-12935.
ABSTRACT
| FULL TEXT
Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies
Lin et al.
Hum Mol Genet 2011;20:1763-1775.
ABSTRACT
| FULL TEXT
GPR56-related bilateral frontoparietal polymicrogyria: further evidence for an overlap with the cobblestone complex
Bahi-Buisson et al.
Brain 2010;133:3194-3209.
ABSTRACT
| FULL TEXT
Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies
Chan et al.
Hum Mol Genet 2010;19:3995-4006.
ABSTRACT
| FULL TEXT
Characterization of site-specific O-glycan structures within the mucin-like domain of {alpha}-dystroglycan from human skeletal muscle
Nilsson et al.
Glycobiology 2010;20:1160-1169.
ABSTRACT
| FULL TEXT
Zebrafish models for human FKRP muscular dystrophies
Kawahara et al.
Hum Mol Genet 2010;19:623-633.
ABSTRACT
| FULL TEXT
Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients
Bourteel et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:1405-1408.
ABSTRACT
| FULL TEXT
Midbrain-hindbrain involvement in lissencephalies
Jissendi-Tchofo et al.
Neurology 2009;72:410-418.
ABSTRACT
| FULL TEXT
Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies
Ackroyd et al.
Brain 2009;132:439-451.
ABSTRACT
| FULL TEXT
Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP)
Thornhill et al.
Brain 2008;131:1551-1561.
ABSTRACT
| FULL TEXT
Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan
Godfrey et al.
Brain 2007;130:2725-2735.
ABSTRACT
| FULL TEXT
New POMT2 mutations causing congenital muscular dystrophy: Identification of a founder mutation
Yanagisawa et al.
Neurology 2007;69:1254-1260.
ABSTRACT
| FULL TEXT
|